EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Role of Coproporphyrins As Endogenous Biomarkers for Organic Anion Transporting Polypeptide 1B Inhibition–Progress from 2016 to 2023

Yurong Lai iD

Drug Metabolism and Disposition · 2023

DOI: 10.1124/dmd.122.001012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Metabolism and Disposition, 2023. Verfasst von Yurong Lai. Beteiligte Einrichtung: Drug Metabolism, Gilead Sciences Inc., Foster City, California yurong.lai@gilead.com. Hauptthemen laut MEDLINE: Coproporphyrins, Organic Anion Transporters. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoproporphyrinsOrganic Anion TransportersHumansBiomarkersDrug InteractionsRifampin

Substanzen

BiomarkersCoproporphyrinsOrganic Anion TransportersRifampin

Autor:innen und Institutionen

  • Drug Metabolism, Gilead Sciences Inc., Foster City, California yurong.lai@gilead.com.

ORCID-Profile: Yurong Lai

Zitieren

APA

Lai, Y. (2023). The Role of Coproporphyrins As Endogenous Biomarkers for Organic Anion Transporting Polypeptide 1B Inhibition–Progress from 2016 to 2023. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.122.001012

Vancouver

Lai Y. The Role of Coproporphyrins As Endogenous Biomarkers for Organic Anion Transporting Polypeptide 1B Inhibition–Progress from 2016 to 2023. Drug Metabolism and Disposition. 2023. doi:10.1124/dmd.122.001012

BibTeX
@article{Lai2023,
  author = {Lai, Yurong},
  title = {The Role of Coproporphyrins As Endogenous Biomarkers for Organic Anion Transporting Polypeptide 1B Inhibition–Progress from 2016 to 2023},
  journal = {Drug Metabolism and Disposition},
  year = {2023},
  doi = {10.1124/dmd.122.001012}
}
Kostenlos starten →